Quick Answer
TherapeuticsMD, Inc. reported Operating Income of -$4.39 million for fiscal year 2025.
TherapeuticsMD, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.39M | +28.2% |
| 2024 | -$6.11M | +28.3% |
| 2023 | -$8.52M | -815.6% |
| 2022 | $1.19M | +101.5% |
| 2021 | -$79.58M | +48.8% |
| 2020 | -$155.54M | -2.9% |
| 2019 | -$151.21M | -16.1% |
| 2018 | -$130.22M | -67.7% |
| 2017 | -$77.63M | +14.0% |
| 2016 | -$90.25M | -5.9% |
| 2015 | -$85.19M | -57.6% |
| 2014 | -$54.04M | -109.4% |
| 2013 | -$25.81M | -59.8% |
| 2012 | -$16.15M | -197.5% |
| 2011 | -$5.43M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$862.0K | +24.0% | -24.0% |
| June 30, 2025 | -$695.0K | +75.1% | +20.2% |
| March 31, 2025 | -$871.0K | +23.7% | +23.2% |
| September 30, 2024 | -$1.13M | +36.0% | +59.3% |
| June 30, 2024 | -$2.79M | -12.8% | -144.2% |
| March 31, 2024 | -$1.14M | +57.2% | +35.6% |
| September 30, 2023 | -$1.77M | +87.8% | +28.3% |
| June 30, 2023 | -$2.47M | +83.4% | +7.3% |
- TherapeuticsMD, Inc. showed an increase of +28.2% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, TherapeuticsMD, Inc.’s operating income has grown by 19.1% (from -$5.43 million to -$4.39 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: